LQDA (liquidia.com) Bozor qiymatining balans qiymatiga nisbati

Liquidia Corp (LQDA) kompaniyasining rasmiy ramzlari

Liquidia Corporation (LQDA) dori ishlab chiqarishda tashqi pudratchilarga tayanadi va tayyor mahsulotlarni ishlab chiqarishni yirik zavodlarga topshiradi. Shu bilan birga, geosiyosiy keskinliklar va sanksiyalar reagentlar yetkazib berishni murakkablashtirmoqda va mojarolar hududlaridagi o'pka kasalliklari dorilarini sinovdan o'tkazish jarayonlarini buzmoqda. Jori ko'rsatkich 20.94 ni tashkil etadi. Analitik qulaylik uchun taqdim etilgan ushbu kunlik narxlar grafigi quyida mavjud bo'lib, u ixtisoslashgan muhandislar va ekspertlarning barqaror ishchi kuchiga tegishli ma'lumotlarni to'ldiradi.

LQDA Liquidia Inc.: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Liquidia Corp (LQDA) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Liquidia Corporation|LQDA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Liquidia Technologies|LQDA - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Liquidia|LQDA - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati liquidia.com|LQDA - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Liquidia Corporation|LQDA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Liquidia Technologies|LQDA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Liquidia Technologies|LQDA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Liquidia
Kompaniyaning dastlabki tahlili:Liquidia Corporation - LQDA
Liquidia Technologies original mahsuloti

Ushbu koeffitsiyent sof aktivlarning bozor qayta baholanishini aks ettirib, investorlarning intellektual kapital uchun balans qiymatidan yuqori premium to'lashga tayyorligini ko'rsatadi. Liquidia Corporation (LQDA) kompaniyasining P/B koeffitsiyenti o'zgarishlarini tahlil qilish orqali, bozor uning inhalatsiya texnologiyalari patent himoyasini qanchalik samarali kapitallashtirayotganini baholash mumkin, bu esa aksiya narxining biofarmatsevtika biznesining haqiqiy resurslariga nisbatan qanchalik hadda ortiq baholanganini aniqlash imkonini beradi.

Asosiy raqobatchilar

HLN: Bozor kapitallashuvining balans qiymatiga nisbati|KVUE (kenvue.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Galapagos (GLPG)|ANIP: Balans qiymatiga nisbatan bozor qiymati|MNKD (MannKind Corp.) - Bozor qiymatining balans qiymatiga nisbati|Amphastar Corp (AMPH) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HYFT (ipatherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati ABVC BioPharma, Inc. ABVC|Bozor qiymatining balans qiymatiga nisbati Cumberland Pharmaceuticals Inc CPIX|Bozor kapitallashuvining balans qiymatiga nisbati QNTM (Quantum BioPharma Limited)|FGEN: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati TELO (Telomir Pharmaceuticals)|Bozor qiymatining xususiy kapitalga nisbati Rani Therapeutics Holdings, Inc.|SNYR (Synergy CHC Corp.) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Rallybio Corp.|LEXX (Lexaria Bioscience) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Pulmatrix Corporation (PULM)|PTHL - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Aptorum Group Ltd APM|Bozor kapitallashuvining balans qiymatiga nisbati LYRA (Lyra Therapeutics)|IBO - Balans qiymatiga nisbatan bozor kapitallashuvi|TNFA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati cbdMD|PRFX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Auris Medical|Bozor kapitallashuvining balans qiymatiga nisbati LIPO (Lipella Pharmaceuticals, Inc.)|Kapitallashuvning sof aktivlarga nisbati OPTN (OptiNose Inc)|PIRS: Bozor qiymatining balans qiymatiga nisbati|Procaps Group Corp - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Petros Pharmaceuticals (PTPI)|QLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati ACELYRIN (SLRN)|TFFP (TFF Pharmaceuticals Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi